Emerging biomarker for immunotherapy of non-small cell lung cancer: tumor mutation burden (TMB) and latest progress in related research field

Saved in:
Bibliographic Details
Published inZhonghua bing li xue za zhi Vol. 48; no. 12; p. 987
Main Authors Ma, J, Zeng, X, Zhang, B
Format Journal Article
LanguageChinese
Published China 08.12.2019
Subjects
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Humans
Immunotherapy
Lung Neoplasms
Mutation
Online AccessGet more information
ISSN0529-5807
DOI10.3760/cma.j.issn.0529-5807.2019.12.018

Cover

More Information
ISSN:0529-5807
DOI:10.3760/cma.j.issn.0529-5807.2019.12.018